Harmony Biosciences Holdings, Inc. reports preliminary Q2 results (HRMY:NASDAQ)
Harmony Biosciences (HRMY) Q2 revenue hits $261M; 2026 guidance reaffirmed at $1.0Bâ$1.04B. Get key insights before Aug.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Harmony Biosciences (HRMY) Q2 revenue hits $261M; 2026 guidance reaffirmed at $1.0Bâ$1.04B. Get key insights before Aug.
Harmony Biosciences Holdings, Inc. reports preliminary Q2 results (HRMY:NASDAQ) | Seeking Alpha
Save
Play
(
<1min
)
Comments
Harmony Biosciences Holdings, Inc.
press release
(
HRMY
): Q2Â Revenue of $261M.
Reaffirms 2026 Net Revenue Guidance of $1.0 Billion to $1.04 Billion
Â
Full Q2 2026 Financial Results and Business Updates to be Reported on August 4, 2026
More on Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. (HRMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Harmony Biosciences Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript
Harmony Bio drops after CFO exit
Harmony outlines $1B-$1.04B 2026 net revenue plan while targeting pitolisant GR PDUFA in Q1 2027
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
End of an era? Falling buybacks, rising share counts signal shift in market dynamics (SPY:NYSEARCA)
Buyback era may be ending as S&P 500 share counts rise and repurchases decline, signaling a new capex cycle.
Bank7 projects Q3 expenses of $9.5M-$9.7M while M&A process targets September 3 auction end date (NASDAQ:BSVN)
Bank7 (BSVN) Q2 2026 earnings call highlights: core NIM 4.53â4.55%, deposit costs ~2.3%, Q3 expenses guide, loan/M&A outlookâread now.
H.B. Fuller Declares $0.245 Quarterly Dividend, Sustaining Steady Shareholder Returns
H.B. Fuller announces a quarterly dividend of $0.245 per share, continuing its long-standing policy of rewarding shareholders. This article analyzes the dividend's stability, industry context, and future growth potential for U.S. stock investors.
Accelerate Diversified Credit Income Fund ETF declares $0.13 dividend (TSX:INCM:CA)
Accelerate Diversified Credit Income Fund ETF (INCM:CA) declares a $0.13 monthly dividendâpayable Aug. 10.